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Cytotoxic effect of Shiga toxin-1 on human glomerular epithe- endothelial cell types [3–5]. This paradigm of renal dam-
lial cells. age in Stx HUS was changed, however, by studies impli-
Background. Shiga toxin-1 (Stx-1) has been implicated in cating renal epithelial cells as targets of Stx action. Ofthe pathogenesis of postdiarrheal hemolytic-uremic syndrome
these epithelial cells, proximal tubules have been the(Stx HUS). Endothelial cells had been felt to be the primary
first to be clearly identified. Stx-1 (an isoform of Stxrenal target of Stx-1; however, recent studies suggest that renal
epithelial cells may also be responsive. To further examine this involved in Stx HUS) binds to renal cortical tubular
issue, we evaluated the responsiveness of human glomerular epithelial cells [4, 6, 7]. Furthermore, cultured human
epithelial cells (GECs) to the cytotoxic effects of Stx-1. proximal tubule cells contain extremely high levels ofMethods. Cultured GECs were exposed to Stx-1 in the pres-
Gb3 (galactose-a-1,4, galactose-b-1,4, glucose-ceramide),ence and absence of a variety of inflammatory factors likely
the cognate binding site of Stx, and are highly sensitiveto be elevated in the kidney or serum of patients with Stx
HUS. Cell survival, protein synthesis, total cell Gb3 levels and to Stx-1 cytotoxicity [6]. Thus, proximal tubules may be
synthesis, and Stx-1 binding were measured. an important early target of Stx-1 and could contribute
Results. GECs were sensitive to Stx-1, with an LD50 of ap- to Stx HUS-associated acute renal failure. The findingproximately 1027 g/L (1.4 pmol/L). Interleukin-1 (IL-1), lipo-
that renal tubular epithelial cells were responsive to Stx-1polysaccharide (LPS), tumor necrosis factor-a (TNF-a), and
raised the possibility that other renal epithelial cell typesbutyrate increased Stx-1 cytotoxicity and total cell Gb3 levels.
These agents, with the exception of TNF-a, also increased could also be important targets of the toxin. Of these,
Stx-1 binding to GECs. IL-6 failed to alter Stx-1 toxicity, bind- glomerular epithelial cells (GECs) are of great interest.
ing, or Gb3 content. Stx modulation of GEC function could clearly have aConclusions. These studies indicate that GECs are sensitive
significant impact on glomerular function through alter-to the cytotoxic effects of Stx-1 and that inflammatory factors
ations in glomerular filtration rate, vasoactive factor pro-can increase toxin responsiveness. GECs may be a target of
Stx-1 action in Stx HUS. duction, basement membrane integrity, or other parame-
ters. Indeed, recent studies raise the possibility that
GECs may be a site of Stx action. Adult human podo-
Postdiarrheal hemolytic-uremic syndrome [Shiga toxin cytes in vivo can bind Stx-1, albeit relatively weakly [8].
(Stx) HUS] is the leading cause of acute renal failure in Furthermore, primary cultures of human GECs have
children [1, 2]. Until recently, renal damage in Stx HUS been reported to be sensitive to the cytotoxic effect of
had been generally thought, on the basis of histologic Stx-1, although the magnitude of Stx-1 binding, Gb3
studies, to primarily involve endothelial cells. Support expression and synthesis, or factors affecting Stx-1 toxic-
for endothelial cell targeting in Stx HUS was lent by ity were not fully assessed [9]. Consequently, the first
observations that the putative pathogenic toxin, Stx, had part of the present study was undertaken to more fully
a relatively potent cytotoxic effect on cultured renal mi- evaluate the cytotoxic effect of Stx-1 on GECs.
crovascular endothelial cells as compared with nonrenal Numerous studies have indicated that Stx cytotoxicity
can be potentiated by inflammatory factors in which pro-
duction may be enhanced in Stx HUS. Lipopolysaccha-
1See Editorial by Kaplan and Meyers, p. 2650 ride (LPS), interleukin-1 (IL-1), and tumor necrosis fac-
tor (TNF-a) increase the cytotoxic effect of Stx onKey words: interleukin-1, butyrate, lipopolysaccharide, tumor necrosis
factor, hemolytic uremic syndrome, acute renal failure. human endothelial cells [10, 11]. Butyrate, which may
be elevated in the circulation of patients with Stx HUSReceived for publication August 6, 1999
because of disruption of colonic epithelium, sensitizesand in revised form October 22, 1999
Accepted for publication January 2, 2000 human umbilical vein endothelial cells (HUVECs) to Stx
toxicity [12]. Inflammatory factors may also up-regulateÓ 2000 by the International Society of Nephrology
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epithelial cell sensitivity to Stx-1 cytotoxicity: IL-1, LPS, on ice and GEC media (M199 1 20% FBS 1 100 mg/mL
endothelial growth supplement (PerImmune) 1 100and butyrate increase proximal tubule responsiveness to
Stx-1 [6]. Hence, it would be important to clarify the U/mL penicillin/streptomycin added. Glomerular rem-
nants were centrifuged at 2000 3 g, resuspended in GECrole of inflammatory factors that are likely to be elevated
in Stx HUS on GEC responsiveness to Stx-1. Accord- medium, and plated onto 10 cm tissue culture dishes.
Primary cultures and subcultures were maintained atingly, the second goal of the current study was to examine
the effect of inflammatory factors on the cytotoxic effect 378C in a 5% CO2 environment. Plates were left undis-
turbed for the next five to seven days to facilitate primaryof Stx-1 on GECs.
outgrowth of cells from glomeruli. When the plates were
approximately 40% confluent (greater degrees of con-
METHODS
fluence were associated with mesangial cell outgrowth),
Reagents cells were trypsinized and passaged. All cells were stud-
ied after no more than three passages.Human kidneys were obtained from 10 different pa-
tients undergoing nephrectomies for renal cell carcinoma Cell purity was assessed by immunofluorescent stain-
ing. Primary antihuman antibodies used were mouseor Wilm’s tumor, aged 7 months to 65 years, from various
hospitals in the Salt Lake Valley according to University antifactor VIII-related antigen (Boehringer Mannheim,
Indianapolis, IN, USA), mouse anti-PECAM (R&D Sys-of Utah Institutional Review Board-approved protocols.
Vero cells (African Green Monkey kidney) were obtained tems), mouse anti–E-selectin (R&D Systems), mouse
anticytokeratin-18 (Sigma), mouse anticytokeratin-19from American Type Tissue Collection (ATCC #CRL-81;
Rockville, MD, USA). Fetal bovine serum (FBS) was (Sigma), mouse antipan-cytokeratin (reacts poorly with
cytokeratin 18 and not with 19; Sigma), rabbit anti–WT-1from Hyclone (Logan, UT, USA). Glacial acetic acid
was from Mallinckrodt (Paris, KY, USA). Ethanol was (Santa Cruz, Santa Cruz, CA, USA), mouse antivimentin
(R&D Systems), and mouse antimyosin (Accurate, West-from Quantum Chemical Co. (Anaheim, CA, USA). Tryp-
sin/ethylenediaminetetraacetic acid (EDTA), penicillin/ bury, NY, USA). Secondary antibodies were mouse
antirabbit IgG (Sigma) and rabbit antimouse IgG (Boeh-streptomycin, l-glutamine, Dulbecco’s modified Eagle’s
medium (DMEM):F12, and M199 were purchased from ringer). Positive controls were used for all staining
experiments: primary cultures of HUVECs (kindly pro-GIBCO/BRL (Gaithersburg, MD, USA), and polyisobu-
tylmethacrylate was from Aldrich Chemical Corp. (Mil- vided by Dr. Tom McIntyre, University of Utah, Salt
Lake City, USA), human mesangial cells P3-P5 (Clon-waukee, WI, USA). All tissue culture flasks, dishes, and
multiwell plates were Falcon Brand (Becton Dickinson, etics, Palo Alto, CA, USA), and human proximal tubular
cells P2-P3 (Clonetics). Freshly isolated human glomer-Lincoln Park, NJ, USA). 3H-leucine and 125I-goat anti-
mouse IgG were from DuPont NEN (Boston, MA, uli also served as positive controls.
All GECs were studied under growth-arrested condi-USA). Na 125I was from ICN (Costa Mesa, CA, USA),
and UDP-14C galactose was from Amersham (Arlington tions. Barely confluent GECs were placed in DMEM:F12
containing 2 mmol/L l-glutamine and 100 U/mL penicil-Heights, IL, USA). Recombinant IL-1b (IL-1), IL-6, and
TNF-a (TNF-a) were from R&D Systems (Minneapolis, lin/streptomycin for 24 hours prior to any experimental
maneuvers.MN, USA). Lactosylceramide and globotriaosylcera-
mide (Gb3) were from Matreya (Pleasant Gap, PA, Vero cells were grown and studied in M199 containing
2.2 g/L sodium bicarbonate, 25 mmol/L HEPES, 100USA). Stx-1 was isolated and purified as previously de-
scribed [6]. A mouse monoclonal antibody to the B-sub- U/mL penicillin/streptomycin, and 5% FBS.
unit of Stx-1 [13] was purified from a hybridoma cell
Neutral red cytotoxicity assayline, 13C4 (ATCC), as previously described [6].
The neutral red cytotoxicity assay was adapted from
Cell culture previously described protocols [14, 15]. Confluent GECs
in 96-well plates were exposed to 1025 to 10211 g/L Stx-1Renal cortical slices were minced, pushed, and rinsed
through a stainless steel screen (60 mesh, Fisher, Hous- or 0.1 to 100 mmol/L cycloheximide (CHX) for 0 to 96
hours. Two hundred microliters of neutral red media (50ton, TX, USA) and filtered through sieves with pore
sizes of 100 mesh for adults or 140 mesh for children. mg/mL neutral red in M199 containing 5% FBS) were
then added to each well and incubated for two to threeThe glomeruli, which were retained by the 100 or 140
mesh sieves, were centrifuged at 2000 3 g for three hours at 378C in a 5% CO2 incubator. Cells were then
washed with 200 mL 1% CaCl2 1 1% formaldehyde andminutes and suspended in phosphate-buffered saline
(PBS). Glomeruli were then incubated at 378C for 2 to solubilized in 200 mL 1% acetic acid in 50% ethanol.
Absorption was read at 450 nm on a Molecular Devices15 minutes in 1 mg/mL collagenase (type IV; Sigma, St.
Louis, MO, USA) in M199. When the glomerular size ThermoMax Microplate reader (Menlo Park, CA, USA).
For studies examining the effect of inflammatory fac-was reduced by about 50 to 75%, the tube was placed
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tors on Stx-1 or CHX toxicity, GECs were incubated discussed later in this article) in 2% goat serum/TBST
with varying concentrations of LPS, butyrate, IL-1, IL-6, for one hour, washed, and incubated with 0.1 mg/mL
or TNF for 4 to 48 hours in growth-arrest media before 125I-goat antimouse IgG in 2% goat serum/TBST for one
the addition of the cytotoxic agent. Subsequently, Stx-1 hour. Plates were then washed and air dried, and specific
(1028 g/L) or CHX (10 mmol/L) were added to the media binding was visualized by autoradiography. Gb3 concen-
already on the cells and incubated for an additional 72 trations were calculated by densitometry using Gaussian
hours, followed by analysis of neutral red uptake. density distribution with Eagle Eye II ONE-Dscan soft-
ware (Stratagene, La Jolla, CA, USA).3H-leucine incorporation
The results of the Gb3 quantitation were standardized
Glomerular epithelial cells were grown and assayed for cell number by cell counting and total protein deter-
in 24-well plates. Cells were exposed to 1025 to 10211 g/L mination. Prior to centrifugation and lipid extraction, a
Stx-1 or 0.1 to 100 mmol/L CHX for 24 to 96 hours. small aliquot of cells was solubilized in 0.1 N NaOH and
The media were then removed, and 250 mL of HBSS mixed with Bradford reagent (Bio-Rad, Richmond, CA,
containing 1 mCi/mL 3H-leucine were added for 20 min- USA), and the protein concentration was determined
utes. Cells were then rinsed with ice-cold HBSS and by measuring absorbance at 590 nm [16]. Quantitative
solubilized in 500 mL 0.1% sodium dodecyl sulfate
comparisons between Gb3 in different cell types or under
(SDS). A 200 mL aliquot was mixed with 25 mL of 200
different experimental conditions did not differ whethermg/mL bovine serum albumin (BSA) and 2 mL 10%
the data were expressed per total cell protein or cell num-tricarboxylic acid (TCA). The precipitate was incubated
ber; for simplicity, all data are expressed per cell number.on ice for 60 minutes and collected on prewetted GF/C
filters (Whatman, Kent, UK) through a vacuum mani- UDP-galactose lactosylceramide
fold, and the filters were washed with 10% ice-cold TCA galactosyltransferase assay
followed by ice-cold 95% ethanol and air dried. Filters
Glomerular epithelial cells were grown in 10 cm disheswere added to scintillation vials with 5 mL Ready Safe
and growth arrested at confluence. Cells were then stimu-scintillation cocktail (Beckmann, Fullerton, CA, USA),
lated with inflammatory factors for 24 hours and wereand the cpm were determined with a Packard 2200CA b
scraped and centrifuged at 1500 r.p.m. The pellet was re-counter (Downers Grove, IL, USA).
suspended in 500 mL 50 mmol/L [n-morpholino]ethane-
Isolation and quantitation of Gb3 sulfonic acid (MES), pH 6.5. Cells were disrupted with
a five-second pulse from an ultrasonic tip processor (am-Glomerular epithelial cells and Vero cells were grown
in six-well plates and growth arrested at confluence. plitude 30 at 25 W; Cole Parmer Instrument Co., Chi-
GECs were stimulated with inflammatory factors for 24 cago, IL, USA) and assayed for total protein using the
hours followed by extraction of total cellular lipids as Bradford method. GalT6 activity was assayed using a
previously described [6]. Cells were washed with ice-cold modification of the method by Mobassaleh, Mishra, and
PBS, scraped off the plates, and centrifuged at 1500 r.p.m. Keusch [17] and as previously described [6]. Lactosylcer-
The cell pellet was extracted three times in 1 mL of 5:10:3 amide (LacCer, 25 nmol) was aliquoted in 2:1 chloro-
chloroform:methanol:water and dried under vacuum. form:methanol and dried. Sodium cholate in water (250
The dried total lipid product was suspended in 2:1 chloro- mg) was added to the dried LacCer and dried under
form:methanol and separated on high-performance thin vacuum, and the dried mixture was incubated for 60 min-
layer chromatography-silica plates (Mallinckrodt Baker utes at 48C. A total volume of 100 mL 50 mmol/L MES,
Inc., Paris, KY, USA) by ascending chromatography in pH 6.5, containing 10 mmol/L MnCl2, 100 mmol/L 59-50:40:10 chloroform:methanol:water containing 0.025%
adenylimidodiphosphate [p(NH)ppA], 250 mmol/L cold
CaCl2. Gb3 standards were run on each plate to permit UDP-galactose, 44 mmol/L UDP-14C galactose (150,000Gb3 quantitation. Total neutral lipid content was deter-
to 400,000 cpm), and 125 mg total cellular protein wasmined by running duplicate plates and visualizing lipids
added to the dried LacCer/sodium cholate. The sampleswith Orcinol spray.
were vortexed briefly and incubated in a slowly agitatingFor immunostaining, these plates were dried, im-
378 water bath for 60 minutes, and the reaction wasmersed in 0.5% polyisobutylmethacrylate in acetone for
stopped by adding 1 mL 2:1 chloroform:methanol. Aone minute, and dried. Plates were then incubated in
Folch partition was established by adding 200 mL 0.1Tris-buffered saline Tween 20 (TBST; 10 mmol/L Tris-
mol/L KCl and the upper phase re-extracted by addingHCl, pH 7.5, 150 mmol/L NaCl, 0.5% Tween 20) con-
500 mL 2:1 chloroform:methanol. The lower phase was re-taining 10% goat serum for 30 minutes, washed in 2%
extracted by adding 500 mL 1:1 methanol:0.1 mol/L KCl.goat serum/TBST, incubated with 1.5 mg/mL Stx-1 in
The lower phases were combined, dried, and chromato-2% goat serum/TBST for two hours, washed, incubated
with 5 mg/mL anti–Stx-1 monoclonal antibody (13C4; graphed as described previously in this article for Gb3.
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Fig. 2. Effect of Stx-1 on 3H-leucine incorporation by GECs (N 5 3Fig. 1. Cytotoxic effect of Shiga toxin-1 (Stx-1) on glomerular epithelial
each data point). Cells were incubated with Stx-1 for (d) 24, (s) 48cells (GECs; N 5 12 each data point). Cells were incubated with Stx-1
and (j) 72 hours, followed by an addition of 1 mCi/mL 3H-leucine forfor (d) 24, (s) 48 and (j) 72 hours, followed by determination of
20 minutes.neutral red uptake.
Fig. 3. Total globotriaosylceramide (Gb3) con-
tent in GEC and Vero cells. A standard curve
using purified Gb3 is shown on the left side
of the autoradiogram for comparison. Each
experimental lane represents a different cell
culture preparation (Methods section).
Iodination and binding of Stx-1 size (N) refers to the number of experimental and control
samples used for that particular data point.Shiga toxin-1 was iodinated according to the Iodobead
manufacturer’s protocol (Pierce, Rockford, IL, USA)
and as previously described [6]. For 125I-Stx-1 binding RESULTS
assays, GECs in 96-well plates were preincubated in
Human glomerular epithelial cell culturegrowth-arrest media for 24 hours with or without in-
Originally, our aim was to isolate and culture humanflammatory cytokines. At the time of study, media were
glomerular endothelial cells. It was ultimately deter-removed, and 17,000 cpm of 125I-Stx-1 in 100 mL M199
mined that this was best achieved by using a cell-sortingcontaining 5% FBS and 25 mmol/L HEPES plus varying
strategy using antibody-coated magnetic beads; however,concentrations of unlabeled Stx-1 were added for 24
in the process, it was determined that GECs could readilyhours at 48C. Cells were then rinsed with ice-cold HBSS
be cultured. Initial outgrowths of glomerular remnantsand solubilized in 0.1 N NaOH, and cpm were deter-
contained about 95% GECs and 5% endothelial cells,mined on a Packard 5000 g counter.
as determined by immunofluorescent staining. About
Statistics 5% of cells from initial outgrowths (HUVEC and freshly
isolated glomeruli served as positive controls and proxi-All data were analyzed by one-way analysis of variance
mal tubule cells as negative controls) stained positive(ANOVA). Results are expressed as mean 6 SEM. P
with anti-PECAM, anti–E-selectin (after 10-min expo-values , 0.05 were taken as significant. Wherever the
data are expressed as a percentage of control, the sample sure to 100 U/mL TNF-a), and antifactor VIII-related
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Fig. 4. Effect of IL-1 (A), IL-6 (B), TNF-a (C), LPS (D), or butyrate (mmol/L, E) on Stx-1 (10–8 g/L or 140 fmol/L) cytotoxicity on GECs (N 5
8 each data point). *P , 0.001; #P , 0.01, both vs. Stx-1 alone. Cells were preincubated with inflammatory factors for 24 hours prior to exposure
to Stx-1 for 72 hours and subsequent determination of neutral red uptake. Symbols in A are: (j) 10 U/mL IL-1; ( ) 100 U/mL IL-1; ( ) 1000
IL-1. Symbols in B are: (j) 0.5 ng/mL IL-6; ( ) 2 ng/mL IL-6; ( ) 5 ng/mL IL-6. Symbols in C are: (j) 10 U/mL TNF-a; ( ) 100 U/mL TNF-a;
( ) 1000 U/mL TNF-a. Symbols in D are: (j) 0.1 mg/mL LPS; ( ) 1 mg/mL LPS; ( ) 10 mg/mL LPS. Symbols in E are: (j) 0.5 mmol/L butyrate;
( ) 2 mmol/L butyrate; ( ) 5 mmol/L butyrate.
antigen antibodies. These presumed endothelial cells No endothelial or mesangial cells could be detected
in cultures after the first passage. Passaged cells that hadwere negative for all cytokeratins and for WT-1. About
95% of cells from initial outgrowths stained positive with just attained confluence stained positive for vimentin
and with all cytokeratin antibodies, but were negativeantibodies to pan-cytokeratin, cytokeratins 18 or 19, and
vimentin, but were negative for myosin or any of the for all endothelial makers. The passaged cells uniformly
exhibited cobblestone morphology typical of epithelialendothelial cell markers described previously in this arti-
cle. Initial outgrowths did not stain positive for WT-1, cell cultures (glomerular endothelial cell cultures also
exhibit cobblestone morphology; however, the individ-although cells within glomerular remnants were positive
for WT-1. ual cells tend to be larger than epithelial cells). Approxi-
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(1.41 6 0.31 mg/107 cells) than did Vero cells (0.64 6
0.086 mg/107, N 5 3, P , 0.025).
Effect of inflammatory factors on Stx-1 cytotoxicity
The effect of IL-1, IL-6, TNF-a, LPS, and butyrate on
the cytotoxic effect of Stx-1 on GECs was examined.
None of these agents alone significantly affected neutral
red uptake; however, GECs exposed to the highest con-
centration (5 mmol/L) of butyrate exhibited increased
granularity and spreading, signs typically associated with
early toxicity. Of the inflammatory cytokines, IL-1 and
TNF-a (Fig. 4 A, C), but not IL-6 (Fig. 4B), enhanced
Stx-1 sensitivity (Stx-1 dose chosen that caused approxi-
mately a 50% reduction in cell viability at 72 h). The
inhibitory effect of IL-1 and TNF-a was evident after 24
and 48 hours, but not 4 hours, of preincubation with the
cytokines before the addition of Stx-1.
Lipopolysaccharide and butyrate also augmented Stx-1
cytotoxicity in GECs (Fig. 4 D, E). Similar to the inflam-
Fig. 4. (Continued). matory cytokines, LPS up-regulation of Stx-1 cytotoxicity
occurred after 24 and 48 hours, but not 4 hours, of preincu-
bation with endotoxin before addition of Stx-1. Butyrate,
particularly at the highest concentration (5 mmol/L), mark-
mately 10% of cells stained positive for WT-1. While it edly increased GEC Stx-1 sensitivity. As noted earlier
has been reported that maintaining confluent GECs in in this article, although butyrate alone did not affect
culture for several days or even weeks leads to morpho- neutral red uptake, it did alter GEC morphology in a
logic changes and increased WT-1 expression [18], we manner suggestive of early toxicity.
found that, in our hands, GECs exhibited increased gran-
Mechanism of inflammatory factor up-regulation ofularity, flattened out, and began detaching when main-
Stx-1 cytotoxicitytained as confluent cultures for greater than one week.
Modulation of cycloheximide cytotoxicity. To test the
Stx-1 cytotoxicity and protein synthesis inhibition specificity of inflammatory factor modulation of Stx-1
Cytotoxicity was assessed by a combination of neutral action, the effect of these agents on CHX, a protein
red uptake, total cell protein, cell number, and cell mor- synthesis inhibitor and cytotoxic agent, was examined.
phology. As described previously, neutral red uptake has It was first necessary to determine a CHX concentration
been determined to correlate well with changes in cell that, like the Stx-1 concentration used in the studies
morphology and be preferable to using cell protein or mentioned earlier in this article, caused approximately
cell number as an indicator of Stx-1 cytotoxicity [6]. Stx-1 a 50% reduction in cell viability. A dose (0.1 to 100
dose dependently killed cultured GECs (Fig. 1). The mmol/L)- and time (24 to 72 h)-response curve revealed
toxic effect of Stx-1 was detectable at the highest concen- that 10 mmol/L CHX killed approximately 40% of GECs
trations by 24 hours; the LD50 of Stx-1 at 72 hours was after 72 hours (N 5 12 each data point, data not shown);
approximately 1027 g/L (1.4 pmol/L). these conditions were used for subsequent studies.
Shiga toxin-1 also dose dependently inhibited protein Interleukin-1, IL-6, TNF-a, and LPS preincubation for
synthesis by GECs, as assessed by 3H-leucine incorpora- 4 to 48 hours, at the maximal concentrations used for
tion (Fig. 2). After 24 hours of exposure, 1027 g/L (1.4 studies on regulation of Stx-1 cytotoxicity, had no effect
pmol/L) Stx-1 reduced protein synthesis by about 80%, on CHX cytotoxicity (N 5 6 each data point; Fig. 5).
while this degree of protein synthesis inhibition was evi- Butyrate increased CHX cytotoxicity, albeit at the high-
dent after 72 hours with 1029 g/L (14 fmol/L) Stx-1. Cell est concentration (5 mmol/L) or the longest time point
death lagged markedly behind protein synthesis inhibi- (48 h). Notably, the butyrate effect was much less pro-
tion, with approximately a 500-fold higher concentration nounced on CHX toxicity as compared with that with
of Stx-1 being required to kill, as compared with inhibit Stx-1.
protein synthesis, in 50% of the cells after 72 hours of Modulation of Gb3 expression, GalT6 activity, and
exposure to the toxin. SLT-1 binding. To test whether cell surface expression
Gb3 was readily detectable in GECs (Fig. 3). By way of Gb3, or some other Stx-1 receptor, could be increased
by inflammatory factors, GECs were incubated with theof comparison, GECs contained more total cellular Gb3
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tended to give the highest enzyme activity, but it did not
achieve statistical significance.
DISCUSSION
The current study demonstrates that GECs bind Stx-1,
synthesize and express Stx-1 binding sites (Gb3), and
are sensitive to the cytotoxic effect of Stx-1. The LD50
of Stx-1 after 72 hours of exposure to GECs was about
1027 g/L (1.4 pmol/L). This compares with an LD50 of
Stx-1 (after 72 h of exposure) of 1029 g/L (14 fmol/L)
for human proximal tubule cells and 1029.5 g/L (4 fmol/L)
for Vero cells [6], 1025 g/L (140 pmol/L) for human mesan-
gial cells (albeit after 48 h) [19], less than 6% of human
glomerular endothelial cells being killed after 24 hours
of exposure to 1024 g/L (1.4 nmol/L) Stx-1, and virtually
no effect of Stx-1 on noncytokine primed HUVECs [11].
Thus, the cytotoxic effect of Stx-1 on GECs appears toFig. 5. Effect of 4 (j), ( ) 24, and ( ) 48 hours of preincubation
with 100 U/mL IL-1, 5 ng/mL IL-6, 100 U/mL TNF-a, 1 mg/mL LPS, occur at toxin concentrations in between the most (proxi-
or 0.5 to 5 mmol/L butyrate on CHX (10 mmol/L) cytotoxicity on GECs mal tubule) and least (mesangial) Stx-1–sensitive renal(N 5 8 each data point). *P , 0.05; #P , 0.01, both vs. control.
cells examined to date. Admittedly, such comparisons
of Stx-1 toxicity are fraught with confounding variables,
including different degrees of cell confluence, different
periods of Stx-1 exposure, and different proliferativevarious agents for 24 hours followed by the determina-
states. With regard to proliferative state, it is importanttion of 125I-Stx-1 binding in the presence of increasing
to note that all GEC studies were conducted underconcentrations of unlabeled Stx-1. While a Kd and Bmax
growth-arrested conditions. The proliferative state cancould potentially be estimated from these curves, such
alter Stx sensitivity: Actively growing cells are more sus-calculations were not made since it was extremely diffi-
ceptible to the toxin than are quiescent cells [20]. Wecult to know the precise molar concentration (and hence
also examined the effect of Stx-1 on proliferating GECsspecific activity) of 125I-Stx-1 due to difficulties in measur-
and found that Stx-1 sensitivity was increased approxi-ing very small concentrations of Stx-1 recovered from
mately 50- to 100-fold (data not shown). Despite thisthe iodination process. Nonetheless, it appears that IL-1,
heightened sensitivity, growth-arrested conditions wereLPS, and butyrate increased total Stx-1 binding (Fig. 6).
used since this presumably more closely mimics the natu-IL-6, which had no effect on Stx-1 toxicity, did not alter
ral state of GECs. In addition, it avoids differences in125I-Stx-1 binding. Finally, TNF-a, which did increase Stx-1
Stx-1 sensitivity caused by fluctuations in the prolifera-cytotoxicity, did not change toxin binding.
tive state of the cells.Since up-regulation of Stx-1 binding has been associ-
Glomerular epithelial cells were exquisitely sensitiveated with increased cellular Gb3 content, the effect of
to Stx-1 inhibition of protein synthesis. The ED50 of Stx-1inflammatory factors on GEC Gb3 levels was assessed.
(24-h exposure) for inhibition of protein synthesis was
An incubation time of 24 hours and the maximal stimula- about 1029 g/L (14 fmol/L); this value is similar to that
tory (of Stx-1 toxicity) concentration of inflammatory observed for proliferating human GECs [9] and com-
substance were chosen. As shown in Figure 7, all agents pares with an ED50 at 24 hours of 1029.5 g/L (4 fmol/L)
that enhanced Stx-1 cytotoxicity (IL-1, TNF-a, LPS, and for growth-arrested human proximal tubule cells and
butyrate) increased the total Gb3 content in GEC. Note proliferating vero cells [6], an ED50 at 24 hours of about
that IL-1, LPS, and butyrate stimulation of cell Gb3 1026 g/L (14 pmol/L) for growth-arrested human mesan-
levels correlated with their up-regulation of Stx-1 bind- gial cells [19], and an ED50 at 24 hours of about 1025
ing; however, TNF-a enhancement of Gb3 content was g/L (140 pmol/L) for proliferating human glomerular
not associated with altered Stx-1 binding. Finally, IL-6 endothelial cells [3]. Again, comparison of cell sensitivi-
had no effect on Gb3 levels; this correlated with the ties must be interpreted cautiously; however, it would
failure of IL-6 to alter Stx-1 binding. appear that GEC sensitivity to Stx-1 protein synthesis
Since an increase in total cellular Gb3 content could inhibition approaches that of the most sensitive renal
be due to increased Gb3 synthesis, the effect of the cells. This conclusion is supported by the finding that
inflammatory factors on GalT6 activity was determined. GECs and human cortical tubular epithelial cells (albeit
both cell types were proliferating) had similar sensitivi-No factor increased total GalT6 activity (Fig. 8). IL-1
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Fig. 6. Effect of 24 hours of incubation with (d)
control, (s) 100 U/mL IL-1, (j) 5 ng/mL IL-6,
(h) 100 U/mL TNF-a, (m) 1 mg/mL LPS, or
(n) 0.5 mmol/L butyrate on binding of 125I-Stx-1
to GECs (N 5 6 each data point). Approxi-
mately 17,000 cpm of 125I-Stx-1 were added per
well for 24 hours at 48C. Cells were washed and
solubilized, and bound cpm were determined.
*P , 0.001 for IL-1 and P , 0.005 for LPS
and P , 0.001 for butyrate, all vs. control; #P ,
0.005 for IL-1 and P , 0.005 for LPS and P ,
0.025 for butyrate, all vs. control; f P , 0.005 for
IL-1 and P , 0.005 for LPS, both vs. control.
ties to Stx-1 inhibition of protein synthesis [9]. It is striking Stx sensitivity [11, 23], although exceptions to this rela-
tionship have been described [24]. Our study did notthat Stx-1 concentrations that almost completely blocked
protein synthesis in GECs were 100- to 500-fold less than directly assess cell surface Gb3 expression, nor did it
evaluate whether Stx-1 binds to receptors other thanconcentrations that caused only a 50% reduction in cell
survival. Such a phenomenon has been previously ob- glycosphingolipids with a gala1-4gal linkage. Nonethe-
less, it seems likely that the high sensitivity of GECs toserved with Stx-1: The toxin caused a 75% reduction in
mesangial cell protein synthesis, but had minimal effect the protein synthesis inhibitory effect of Stx-1 relates, at
least partially, to abundant cell surface Gb3 expression.on cell viability [21]. This toxin effect on mesangial cells
was due to the A-subunit, since the B-subunit given alone As discussed in the introduction, a number of inflam-
matory factors are elevated either locally in the kidneyhad no effect on protein synthesis. Therefore, it would
appear that GECs can survive relatively marked reduc- or in the serum and may be capable of modulating cell
Stx-1 sensitivity. To investigate this, growth-arrestedtions in protein synthesis under the culture conditions
employed. It may be, however, that such degrees of pro- GECs were preincubated with IL-1, IL-6, TNF-a, LPS,
or butyrate at varying doses for up to 48 hours prior totein synthesis inhibition in vivo, where concurrent ische-
mic or other injurious conditions could exist in Stx HUS, the addition of Stx-1 for an additional 72 hours. All of
these factors, with the exception of IL-6, increased GECcould lead to greater GEC death than realized in the
current study. Finally, it should be noted that, while sensitivity to Stx-1. First, IL-1 and LPS had similar effects
on Stx-1 toxicity. Both agents increased GEC sensitivitybeyond the scope of the present study, Stx-1 might kill
GECs via induction of apoptosis and not solely through to the cytotoxic effects of Stx-1. This up-regulation was
associated with augmented Stx-1 binding and increasedinhibition of protein synthesis. Such a possibility is sup-
ported by observations that Stx-1 causes apoptosis in total cell Gb3 content. The observation that none of
these factors altered GalT6 activity suggests several pos-Burkitt lymphoma cells [22]; however, recent studies in
proliferating GECs have detected no effect of Stx-1 on sibilities. It is conceivable that translocation of Gb3 to
the cell membrane was enhanced and/or removal of Gb3DNA fragmentation [9].
Glomerular epithelial cells contain relatively abundant from the cell membrane was reduced. Alternatively, it
is possible that while total GalT6 activity was unchanged,Gb3 levels; in the current study, they exceeded the Gb3
content of Vero cells. Gb3 content generally parallels these inflammatory factors may have altered the form
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Fig. 8. Effect of 24-hour incubation with 100 U/mL IL-1, 5 ng/mL IL-6,Fig. 7. Effect of 24-hour incubation with 100 U/mL IL-1, 5 ng/mL IL-6,
100 U/mL TNF, 1 mg/mL LPS, or 0.5 mmol/L butyrate on GalT6 activity1000 U/mL TNF, 1 mg/mL LPS, or 0.5 mmol/L butyrate on total Gb3
in GECs (N 5 3 each data point). Control GalT6 activity was 0.36 6content in GECs (N 5 6 each data point). *P , 0.025; #P , 0.01, both
0.04 densitometry units (Methods section).vs. control. Lanes were loaded with an equal weight of total cellular
lipids (Methods section).
toxic effect. Furthermore, butyrate was the only agentof Gb3 that was synthesized. The Gb3 assay employed
that enhanced CHX cytotoxicity, supporting the notion
in the current study detects Gb3 by Stx-1 binding to
that, in addition to modulation of Stx-1 binding, butyrate
the chromatography plate. In contrast, the GalT6 assay
nonspecifically enhances cell toxicity associated with in-
measures incorporation of 14C-galactose into Gb3, but hibition of protein synthesis. It should be noted that
does not assess the ability of newly synthesized Gb3 to relatively similar results were seen with butyrate treat-
bind Stx-1 (the assay is not this sensitive). Since galactose ment of human proximal tubular cells [6].
could be added in a b1-3 linkage (does not bind Stx-1) Tumor necrosis factor-a also augmented Stx-1 cyto-
or an a1-4 linkage (binds Stx-1), it is possible that IL-1 toxicity in GECs, increased total Gb3 content, and did
and LPS caused a relative shift to a1-4 linkages without not change GalT6 activity. Unlike the other factors,
an overall increase in GalT6 activity. This possibility TNF-a did not change Stx-1 binding to GECs. This find-
might be tested by quantitating GalT6 activity in the ing was surprising but not unprecedented. In a previous
presence and absence of a- or b-galactosidases; however, study, our group found that butyrate elevated proximal
we have attempted such studies (data not shown) and tubule cell Gb3 content and Stx-1 cytotoxicity, but did
found them to be relatively nonquantitative. Taken to- not alter Stx-1 binding [6]. Therefore, it is evident that
gether, these considerations suggest that IL-1 and LPS the total Gb3 content does not necessarily reflect cell
increase Stx-1 cytotoxicity, at least in part, by increasing surface Gb3 expression, although the mechanisms re-
toxin binding to the cell membrane. This does not, how- sponsible for this are unclear. In addition, TNF-a in-
ever, preclude other mechanisms by which these in- creased proximal tubule cell Stx-1 sensitivity, but did not
flammatory factors might increase Stx-1 sensitivity. For change Gb3 content or Stx-1 binding [6]. Thus, it appears
example, LPS increases proximal tubule sensitivity to that TNF-a can increase Stx-1 sensitivity in both GECs
Stx-1 cytotoxicity; however, it does not alter Stx-1 bind- and human proximal tubule cells through mechanisms
ing or Gb3 content in these cells [6], suggesting that distal to Stx-1 binding.
LPS has the potential to augment Stx-1 action through At this point, the significance of Stx-1 inhibition of
mechanisms independent of Stx-1 binding. This observa- GEC protein synthesis or induction of cytotoxicity is
tion also underscores the finding that inflammatory fac- unknown. GEC injury has not been described as a promi-
tor up-regulation of Stx-1 sensitivity is not necessarily nent feature of Stx HUS; however, it is difficult to iden-
similar in all responsive cell types. tify GEC damage morphologically other than by nonspe-
Butyrate increased GEC responsiveness to Stx-1; this cific fusion of foot processes. Proteinuria is variable,
effect was associated with increases in Gb3 content and while hematuria and red cell casts are commonly ob-
Stx-1 binding, but no change in GalT6 activity, in a man- served, suggesting some damage to podocytes [2]. Severe
ner similar to that seen with IL-1 and LPS. In contrast, acute renal insufficiency has been described in the ab-
sence of histologically apparent endothelial cell damagebutyrate (at the doses used) appeared to have a direct
Hughes et al: Stx-1 cytotoxicity in GECs 2359
with carbohydrates, with fresh frozen human tissues and hemato-[2], suggesting that other renal cells types could be in-
poietic tumors. J Cancer 48:848–854, 1991
volved. Conceivably, GECs could be early targets of 9. Williams J, Boyd B, Nutikka A, Lingwood C, Barnett Foster
D, Milford D, Tayor C: A comparison of the effects of verocyto-Stx-1 with resultant stimulation of inflammatory cyto-
toxin-1 on primary human renal cell cultures. Toxicol Lett 105:47–kine, procoagulant, chemotactic, extracellular matrix-
57, 1999
degrading enzyme, or vasoactive factor release. Regard- 10. Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG: Shiga
toxin-associated hemolytic uremic syndrome: Interleukin-1b en-less of how GEC injury contributes to renal dysfunction
hancement of shiga toxin cytotoxicity toward human vascular endo-in Stx HUS, it is evident that this cell type is highly thelial cells in vitro. Infect Immun 61:3886–3891, 1993
sensitive to at least the protein synthesis inhibitory ef- 11. van de Kar N, Monnens LAH, Karmali MA, van Hinsbergh
VWM: Tumor necrosis factor and interleukin-1 induce expressionfects of Stx-1 and that inflammatory factors likely to be
of the verocytotoxin receptor globotriaosylceramide on humanelevated in the kidney of patients with Stx HUS augment endothelial cells: Implications for the pathogenesis of the hemolytic
GEC responsiveness to Stx-1. Clearly, further studies uremic syndrome. Blood 80:2755–2764, 1992
12. Louise CB, Kaye SA, Boyd B, Lingwood CA, Obrig TG: Shigaare needed to clarify the effects of Stx-1 on GECs.
toxin-associated hemolytic uremic syndrome: Effect of sodium bu-
tyrate on sensitivity of human umbilical vein endothelial cells to
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